November 25 Product: Shorla Oncologys Imkeldi Indication: Several forms of leukemia and other cancers The FDA on Monday signed off on Shorla Oncologys Imkeldi, an oral solution indicated for the treatment of certain types of chronic myeloid leukemia and acute lymphoblastic leukemia, as well as other cancers such as myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis and dermatofibrosarcoma protuberans
Recalls & Warnings June 16, 2004 Ads for Various Diet Pills and Topical Gels Dont Cut the Fat, Says the FTC On June 16, 2004, The Federal Trade Commission (FTC)charged a Utah-based company, five related corporations, and three individuals operating as a common enterprise with making numerous false and unsubstantiated claims for weight-loss and fat-loss gels and supplements
La molcula que cambi el juego Orforglipron, desarrollado por la farmacutica Eli Lilly, es uno de los primeros medicamentos orales que acta directamente sobre el receptor GLP-1 sin necesidad de imitar estructuralmente a la hormona natural
Another study found no effect on drinking among individuals with AUD, but it did find a reduction in heavy drinking days for those who have both an AUD and comorbid obesity
With rigorouslylab-tested sterility, this convenient 10-vial pack ensures a consistent, high-quality supply for all your professional needs
Pureza: 99% certificada por HPLC Especificaciones tcnicas Presentacin: polvo liofilizado en vial de 10mg Pureza: 99% (COA disponible) Almacenamiento: liofilizado a 20C